HuttoSKRapalinoOVennaN. Spinomedullary Weston Hurst Syndrome after COVID-19 and influenza co-infection: a case report. Neurohospitalist2022;12(2):337-340.
2.
TobinWOGuoYKreckeKN, et al.Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2017;140:2415-2425.
3.
KoelmanDLHChahinSMarSS, et al.Acute disseminated encephalomyelitis in 228 patients. Neurology. 2016;86(22):2085-2093.
4.
FuYLiYGuoE, et al.Dynamics and correlation among viral positivity, seroconversion, and disease severity in COVID-19. Ann Intern Med. 2021;174(4):453-461.
5.
HeXLauEHYWuP, et al.Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672-675.
6.
CarmoAPereira‐VazJMotaV, et al.Clearance and persistence of SARS‐CoV‐2 RNA in patients with COVID‐19. J Med Virol. 2020;92(10):2227-2231.
7.
AriñoHHeartshorneRMichaelBD, et al.Neuroimmune disorders in COVID-19. J neurol. 2022;269(6):2827-2839.
8.
ManzanoGSMcEntireCRSMartinez-LageMMateenFJHuttoSK. Acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalitis following COVID-19. Neurol - Neuroimmunol Neuroinflamm. 2021;8(6):e1080.
9.
WangYWangYHuoLLiQChenJWangH. SARS-CoV-2-associated acute disseminated encephalomyelitis: A systematic review of the literature. J Neurol. 2022;269(3):1071-1092.
10.
RománGCGraciaFTorresAPalaciosAGraciaKHarrisD. Acute transverse myelitis (ATM): Clinical review of 43 patients with COVID-19-associated atm and 3 post-vaccination atm serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Front immunol. 2021;12:653786.
11.
GigliGLVogrigANiloA, et al.HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome. Neurol Sci. 2020;41(12):3391-3394.
